0001714899-22-000092.txt : 20220606
0001714899-22-000092.hdr.sgml : 20220606
20220606200758
ACCESSION NUMBER: 0001714899-22-000092
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220602
FILED AS OF DATE: 20220606
DATE AS OF CHANGE: 20220606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLATLEY JAY T
CENTRAL INDEX KEY: 0001189130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 22999534
MAIL ADDRESS:
STREET 1: 9885 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
wf-form4_165456046364331.xml
FORM 4
X0306
4
2022-06-02
0
0001714899
Denali Therapeutics Inc.
DNLI
0001189130
FLATLEY JAY T
C/O DENALI THERAPEUTICS INC.
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2022-06-02
4
A
0
5986
0
A
336313
I
See footnote
Stock Option (right to buy)
24.27
2022-06-02
4
A
0
17959
0
A
2032-06-02
Common Stock
17959.0
17959
D
Each share is represented by a Restricted Stock Unit ("RSU") and a contingent right to receive one share of common stock of the Issuer. 100% of the RSUs shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
Shares will be issued directly to The Flatley Family Trust.
Includes 5,986 unvested restricted stock units.
The shares are held of record by The Flatley Family Trust, for which the Reporting Person serves as a trustee.
100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date or (ii) the day preceding the Issuer's next annual meeting of stockholders occurring after the grant date.
/s/ Tyler Nielsen, by power of attorney
2022-06-06